115 related articles for article (PubMed ID: 3115189)
1. Mast-cell stabilization to decrease neurofibroma growth. Preliminary experience with ketotifen.
Riccardi VM
Arch Dermatol; 1987 Aug; 123(8):1011-6. PubMed ID: 3115189
[TBL] [Abstract][Full Text] [Related]
2. A controlled multiphase trial of ketotifen to minimize neurofibroma-associated pain and itching.
Riccardi VM
Arch Dermatol; 1993 May; 129(5):577-81. PubMed ID: 8481017
[TBL] [Abstract][Full Text] [Related]
3. Ketotifen suppression of NF1 neurofibroma growth over 30 years.
Riccardi VM
Am J Med Genet A; 2015 Jul; 167(7):1570-7. PubMed ID: 25974154
[TBL] [Abstract][Full Text] [Related]
4. [Ketotifen inhibits urticaria and tumor progression in neurofibromatosis].
Haustein UF
Dermatol Monatsschr; 1989; 175(9):581-4. PubMed ID: 2511044
[TBL] [Abstract][Full Text] [Related]
5. Ketotifen and neurofibromatosis.
Krause L
Arch Dermatol; 1988 May; 124(5):651-2. PubMed ID: 2452604
[No Abstract] [Full Text] [Related]
6. Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand, but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of
Burks CA; Rhodes SD; Bessler WK; Chen S; Smith A; Gehlhausen JR; Hawley ET; Jiang L; Li X; Yuan J; Lu Q; Jacobsen M; Sandusky GE; Jones DR; Clapp DW; Blakeley JO
Mol Cancer Ther; 2019 Dec; 18(12):2321-2330. PubMed ID: 31527226
[TBL] [Abstract][Full Text] [Related]
7. [Exclusive nodular plexiform neurofibroma. An unusual case of neurofibromatosis type 1].
Benchikhi H; Zeller J; Wolkenstein P; Wechsler J; Vidaud D; Revuz J
Ann Dermatol Venereol; 1995; 122(9):601-3. PubMed ID: 8745684
[TBL] [Abstract][Full Text] [Related]
8. [Successful treatment of cheilitis granulomatosis with potent inhibitors of mediator release--possible involvement of mast cells in the pathogenesis].
Chiba M; Kobayashi M; Shiohara T; Nagashima M
Nihon Hifuka Gakkai Zasshi; 1989 Jul; 99(8):883-9. PubMed ID: 2479786
[TBL] [Abstract][Full Text] [Related]
9. Benefit of ketotifen in patients with eosinophilic gastroenteritis.
Melamed I; Feanny SJ; Sherman PM; Roifman CM
Am J Med; 1991 Mar; 90(3):310-4. PubMed ID: 2003512
[TBL] [Abstract][Full Text] [Related]
10. The role of mast cell stabilization in treatment of postoperative ileus: a pilot study.
The FO; Buist MR; Lei A; Bennink RJ; Hofland J; van den Wijngaard RM; de Jonge WJ; Boeckxstaens GE
Am J Gastroenterol; 2009 Sep; 104(9):2257-66. PubMed ID: 19491822
[TBL] [Abstract][Full Text] [Related]
11. Possible involvement of c-kit receptor and its ligand in increase of mast cells in neurofibroma tissues.
Hirota S; Nomura S; Asada H; Ito A; Morii E; Kitamura Y
Arch Pathol Lab Med; 1993 Oct; 117(10):996-9. PubMed ID: 7692836
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of ketotifen fumarate 0.025% and olopatadine HCl 0.1% ophthalmic solutions in seasonal allergic conjunctivities: a 30-day, randomized, double-masked, artificial tear substitute-controlled trial.
Avunduk AM; Tekelioglu Y; Turk A; Akyol N
Clin Ther; 2005 Sep; 27(9):1392-402. PubMed ID: 16291412
[TBL] [Abstract][Full Text] [Related]
13. Mast cell mediators in asthma. Clinical uses of the inhibitors.
Seropian E; Filip V; Iamandescu I
Allergol Immunopathol (Madr); 1981; Suppl 9():23-7. PubMed ID: 6187197
[No Abstract] [Full Text] [Related]
14. Clinical and therapeutical aspects of cold urticaria (urticaria a frigore).
Seropian E; Iamandescu IB; Filip V
Allergol Immunopathol (Madr); 1984; 12(4):303-11. PubMed ID: 6209972
[TBL] [Abstract][Full Text] [Related]
15. [Ketotifen treatment of chronic urticaria. An open study of therapeutically difficult courses].
Taube KM; Wozniak KD; Lässig W
Z Hautkr; 1985 Dec; 60(23):1878, 1881-2, 1885. PubMed ID: 4090577
[TBL] [Abstract][Full Text] [Related]
16. Effect of ketotifen treatment on cold-induced urticaria.
St-Pierre JP; Kobric M; Rackham A
Ann Allergy; 1985 Dec; 55(6):840-3. PubMed ID: 3907425
[TBL] [Abstract][Full Text] [Related]
17. Ki-67 proliferation-index (MIB-1) of neurofibromas in neurofibromatosis type 1 patients.
Friedrich RE; Hagel C; Brehme Z; Kluwe L; Mautner VF
Anticancer Res; 2003; 23(2A):953-5. PubMed ID: 12820329
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous manifestation of neurofibromatosis: cellular interaction, pigmentation, and mast cells.
Riccardi VM
Birth Defects Orig Artic Ser; 1981; 17(2):129-45. PubMed ID: 6802200
[TBL] [Abstract][Full Text] [Related]
19. Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR.
Lévy P; Vidaud D; Leroy K; Laurendeau I; Wechsler J; Bolasco G; Parfait B; Wolkenstein P; Vidaud M; Bièche I
Mol Cancer; 2004 Jul; 3():20. PubMed ID: 15255999
[TBL] [Abstract][Full Text] [Related]
20. Molecular profiles of neurofibromatosis type 1-associated plexiform neurofibromas: identification of a gene expression signature of poor prognosis.
Lévy P; Bièche I; Leroy K; Parfait B; Wechsler J; Laurendeau I; Wolkenstein P; Vidaud M; Vidaud D
Clin Cancer Res; 2004 Jun; 10(11):3763-71. PubMed ID: 15173083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
